(Q40525285)

21 September 2017

A collaborative health care model for the treatment of irritable bowel syndrome (English)

1 reference

21 September 2017

1 reference

Charles D Gerson

1

1 reference

21 September 2017

Mary-Joan Gerson

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Clinical Gastroenterology and Hepatology

21 September 2017

1 reference

21 September 2017

1

1 reference

21 September 2017

6

1 reference

21 September 2017

446-452

1 reference

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Predictors of health care seeking for irritable bowel syndrome: a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Irritable Bowel Syndrome–Prognosis and Diagnostic Safety

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Prognosis in the irritable bowel syndrome: a 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The irritable bowel syndrome: long-term prognosis and the physician-patient interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The role of anxiety and depression in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

A controlled trial of psychological treatment for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Controlled study of psychotherapy in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

A Rating Instrument For Anxiety Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Functional bowel disorders. A multicenter comparison of health status and development of illness severity index

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The irritable bowel syndrome: review and a graduated multicomponent treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Diary methods: capturing life as it is lived

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The relationship between psychosocial parameters and outcome in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The impact of irritable bowel syndrome on health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

The need for a new medical model: a challenge for biomedicine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Diagnosing and treating patients with refractory functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

Cognitive therapy for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2803%2900218-0

7 January 2021

10.1016/S1542-3565(03)00218-0

Identifiers

DOI

1 reference

release_tvzgxkqmnzgdldabae2dhpesei

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tvzgxkqmnzgdldabae2dhpesei

24 November 2022

mapped directly with Wikidata item

1 reference